Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.Donate to our crowdfunder
To ask Her Majesty’s Government, for each of the last three years for which figures are available, what was the total National Health Service expenditure on drugs and medicines produced by (1) AstraZeneca, (2) Pfizer, and (3) GlaxoSmithKline; and what percentage of the National Health Service’s total expenditure on drugs and medicines each of those figures represents.
This does not include data on NHS use of medicines in hospitals, as comparable current data sources do not take account of the discounts available.
|Net ingredient cost and proportion of all primary care spend by manufacturer, in England, for the years 2011, 2012 and 2013, based on prescription items dispensed in the community in England.1|
|Manufacturer name||Net Ingredient Cost (£000s)||Percentage of all Primary Care||Net Ingredient Cost (£000s)||Percentage of all Primary Care||Net Ingredient Cost (£000s)||Percentage of all Primary Care|
|Total (all primary care expenditure on medicines in England2)||8,164,364||100.0||7,840,390||100.0||7,888,304||100.0|
Prescription Cost Analysis provided by the Health and Social Care Information Centre
This may not include spend on those medicines made by the companies that are also available generically.